AVIR - Atea Pharmaceuticals GAAP EPS of -$0.43 beats by $0.07
2023-05-08 16:13:26 ET
- Atea Pharmaceuticals press release ( NASDAQ: AVIR ): Q1 GAAP EPS of -$0.43 beats by $0.07 .
- Cash, Cash Equivalents and Marketable Securities: $620.5 million at March 31, 2023 compared to $646.7 million at December 31, 2022.
For further details see:
Atea Pharmaceuticals GAAP EPS of -$0.43 beats by $0.07